In our present study, we continued to investigate whether IL‐35 recombinant protein could achieve the same therapeutic effect in K14‐VEGF transgenic psoriasis mouse model and IMQ‐induced psoriasis mouse model. The gene discussed is KRT14; the disease is psoriasis.